However, if glucagon can be used not only to prevent and treat hypoglycaemia but primarily to improve the performance of SC CGM and SC absorption of insulin, this new, innovative and disruptive use of glucagon may fulfil the dream of a true, fully automated AP suitable for most patients with DM1. The gene discussed is GCG; the disease is Hypoglycemia.